Hiscox seeks to calm investor concerns on Covid-19 reinsurance exposures
Hiscox sought to reassure investors on its Covid-19 exposures during its first half earnings call following a 7 percent morning dip in its share price on the back of an $82mn increase in its expected losses from the pandemic.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below